BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21911421)

  • 1. E3 ubiquitin ligase CHIP facilitates Toll-like receptor signaling by recruiting and polyubiquitinating Src and atypical PKC{zeta}.
    Yang M; Wang C; Zhu X; Tang S; Shi L; Cao X; Chen T
    J Exp Med; 2011 Sep; 208(10):2099-112. PubMed ID: 21911421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased A20-E3 ubiquitin ligase interactions in bid-deficient glia attenuate TLR3- and TLR4-induced inflammation.
    Kinsella S; Fichtner M; Watters O; König HG; Prehn JHM
    J Neuroinflammation; 2018 May; 15(1):130. PubMed ID: 29720226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.
    Murphy M; Xiong Y; Pattabiraman G; Qiu F; Medvedev AE
    J Biol Chem; 2015 Jul; 290(31):19218-32. PubMed ID: 26082489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E3 ligase WWP2 negatively regulates TLR3-mediated innate immune response by targeting TRIF for ubiquitination and degradation.
    Yang Y; Liao B; Wang S; Yan B; Jin Y; Shu HB; Wang YY
    Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5115-20. PubMed ID: 23479606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E3 ligase CHIP and Hsc70 regulate Kv1.5 protein expression and function in mammalian cells.
    Li P; Kurata Y; Maharani N; Mahati E; Higaki K; Hasegawa A; Shirayoshi Y; Yoshida A; Kondo T; Kurozawa Y; Yamamoto K; Ninomiya H; Hisatome I
    J Mol Cell Cardiol; 2015 Sep; 86():138-46. PubMed ID: 26232501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor-2 ligand peptidoglycan upregulates expression and ubiquitin ligase activity of CHIP through JNK pathway.
    Meng Y; Chen C; Wang L; Wang X; Tian C; Du J; Li HH
    Cell Physiol Biochem; 2013; 32(4):1097-105. PubMed ID: 24217650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triad3A attenuates pathological cardiac hypertrophy involving the augmentation of ubiquitination-mediated degradation of TLR4 and TLR9.
    Lu X; He Y; Tang C; Wang X; Que L; Zhu G; Liu L; Ha T; Chen Q; Li C; Xu Y; Li J; Li Y
    Basic Res Cardiol; 2020 Feb; 115(2):19. PubMed ID: 32008145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA.
    Konno H; Yamamoto T; Yamazaki K; Gohda J; Akiyama T; Semba K; Goto H; Kato A; Yujiri T; Imai T; Kawaguchi Y; Su B; Takeuchi O; Akira S; Tsunetsugu-Yokota Y; Inoue J
    PLoS One; 2009 May; 4(5):e5674. PubMed ID: 19479062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-specific protease 25 regulates TLR4-dependent innate immune responses through deubiquitination of the adaptor protein TRAF3.
    Zhong B; Liu X; Wang X; Liu X; Li H; Darnay BG; Lin X; Sun SC; Dong C
    Sci Signal; 2013 May; 6(275):ra35. PubMed ID: 23674823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination.
    Huang Z; Nie L; Xu M; Sun XH
    Mol Cell Biol; 2004 Oct; 24(20):8951-62. PubMed ID: 15456869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tyrosine kinase Syk differentially regulates Toll-like receptor signaling downstream of the adaptor molecules TRAF6 and TRAF3.
    Lin YC; Huang DY; Chu CL; Lin YL; Lin WW
    Sci Signal; 2013 Aug; 6(289):ra71. PubMed ID: 23962979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism of the negative regulation of Smad1/5 protein by carboxyl terminus of Hsc70-interacting protein (CHIP).
    Wang L; Liu YT; Hao R; Chen L; Chang Z; Wang HR; Wang ZX; Wu JW
    J Biol Chem; 2011 May; 286(18):15883-94. PubMed ID: 21454478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.
    Piao W; Song C; Chen H; Diaz MA; Wahl LM; Fitzgerald KA; Li L; Medvedev AE
    J Leukoc Biol; 2009 Oct; 86(4):863-75. PubMed ID: 19656901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy-dependent PELI3 degradation inhibits proinflammatory IL1B expression.
    Giegerich AK; Kuchler L; Sha LK; Knape T; Heide H; Wittig I; Behrends C; Brüne B; von Knethen A
    Autophagy; 2014; 10(11):1937-52. PubMed ID: 25483963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E3 ubiquitin ligase TRAF6 inhibits LPS-induced AKT activation in FLT3-ITD-positive MV4-11 AML cells.
    Schnetzke U; Fischer M; Kuhn AK; Spies-Weisshart B; Zirm E; Hochhaus A; Müller JP; Scholl S
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):605-15. PubMed ID: 23263202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase Calpha is involved in interferon regulatory factor 3 activation and type I interferon-beta synthesis.
    Johnson J; Albarani V; Nguyen M; Goldman M; Willems F; Aksoy E
    J Biol Chem; 2007 May; 282(20):15022-32. PubMed ID: 17296604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E3 ligase RNF99 negatively regulates TLR-mediated inflammatory immune response via K48-linked ubiquitination of TAB2.
    Zhang J; Cao L; Gao A; Ren R; Yu L; Li Q; Liu Y; Qi W; Hou Y; Sui W; Su G; Zhang Y; Zhang C; Zhang M
    Cell Death Differ; 2023 Apr; 30(4):966-978. PubMed ID: 36681779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E3 ubiquitin ligase ASB8 negatively regulates interferon via regulating TBK1/IKKi homeostasis.
    Guo Y; Li R; Tan Z; Shi J; Fu Y; Song Y; Zhu M; Zhang L; Huang J
    Mol Immunol; 2020 May; 121():195-203. PubMed ID: 32298923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The E3 ubiquitin ligase RNF182 inhibits TLR-triggered cytokine production through promoting p65 ubiquitination and degradation.
    Cao Y; Sun Y; Chang H; Sun X; Yang S
    FEBS Lett; 2019 Nov; 593(22):3210-3219. PubMed ID: 31432514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer.
    Wang Y; Ren F; Wang Y; Feng Y; Wang D; Jia B; Qiu Y; Wang S; Yu J; Sung JJ; Xu J; Zeps N; Chang Z
    Carcinogenesis; 2014 May; 35(5):983-91. PubMed ID: 24302614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.